Letter: Pension Policies

You are to be commended for the timely article "New Policies Offer Pension Choices To Academic Scientists" (The Scientist, March 5, 1990, page 25). Julia King correctly pointed out that there is the catch that some of the more flexible policies ". . . must first be adopted by the university where the professors are employed." She went on to suggest that employees can lobby for their employers to adopt the new policies. Despite the fact that TIAA-CREF insists that contracts are with individuals

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

You are to be commended for the timely article "New Policies Offer Pension Choices To Academic Scientists" (The Scientist, March 5, 1990, page 25). Julia King correctly pointed out that there is the catch that some of the more flexible policies ". . . must first be adopted by the university where the professors are employed." She went on to suggest that employees can lobby for their employers to adopt the new policies.

Despite the fact that TIAA-CREF insists that contracts are with individuals, it still permits such control to be exercised by employers. There are some 350,000 individuals who hold TIAA-CREF contracts who are no longer working for academic institutions. For those individuals, their options are controlled by their former employers. Further, while TIAA-CREF informs such persons of the options that are available, no one has the responsibility of informing former employees of the options chosen by their former ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Cedric Chernick

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide